LTβR:LIGHT[Biotinylated] Inhibitor Screening Assay Kit

Catalog #
79808
$1,040 *
Size: 96 Reactions
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

The LTβR:LIGHT[Biotinylated] Inhibitor Screening Assay Kit is designed for screening and profiling inhibitors of LIGHT binding to LTβR . This kit comes in a convenient 96-well format, with biotin-labeled LIGHT, purified LTβR , streptavidin-labeled HRP, and assay buffer for 100 binding reactions. The key to this kit is the high sensitivity of detection of biotin-labeled LIGHT by streptavidin-HRP. Only a few simple steps on a microtiter plate are required for the assay. First, LTβR is coated on a 96-well plate. Next, biotinylated LIGHT is incubated with LTβR on the plate. Finally, the plate is treated with streptavidin-HRP followed by addition of an HRP substrate to produce chemiluminescence, which can be measured using a chemiluminescence reader.

Need us to run inhibitor screens or profile your compounds against LTβR:LIGHT[Biotinylated]? Check out our Immunotherapy Biochemical Screening Services.

Synonyms
TNFSF14, lymphotoxin beta receptor, LTBR, LTBR-Fc fusion protein, Tumor Necrosis Factor C Receptor, TNFCR, CD18
Product Info
Storage and Usage
Citations
Assay Kit Format
Chemiluminescent
Materials Required But Not Supplied

PBS (Phosphate buffered saline)
Luminometer or microplate reader capable of reading chemiluminescence
Adjustable micropipettor and sterile tips

Format
Catalog
Number
Component Amount Storage
71112 Human LTBR, Fc-Fusion 10 µg -80 °C Avoid
freeze/
thaw
cycles!
100032 LIGHT, Biotin-Labeled 10 µg -80 °C
79311 3x Immuno Buffer 1 50 ml -20 °C
79728 Blocking Buffer 2 50 ml +4 °C
79742  Streptavidin-HRP 15 µl -20 °C
79742  ELISA ECL Substrate A 6 ml RT
ELISA ECL Substrate B 6 ml RT
79699 96-well white microplate 1 +4°C
UniProt #
LTβR: P36941; LIGHT: O43557
Background
Lymphotoxin β receptor (LTβR) and herpes virus entry mediator (HVEM) are the physiological receptors of LIGHT (tumor necrosis factor superfamily member 14 (TNFSF14) or CD258). The activation of the LTβR/HVEM:LIGHT co-signaling pathways induces the production of pro-inflammatory molecules, like NF-B, chemokines and adhesion molecules. LTβR is up regulated in hepatitis and hepatocellular carcinoma, and influences lipid metabolism and atherosclerosis. It also regulates cell growth and can initiate inflammation related carcinogenesis.
References

Chang, J. H., et al. J Biomed Sci 2005, 12(2): 363-375.
Del Rio, M.L., et al. J. Leukoc. Biol. 2010, 87(2): 223-235